Thrombosis Journal

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Ambulatory management of isolated acute deep venous thrombosis (DVT) is the recommended standard of care in selected populations. However, in practice a significant number of patients continue to be managed as in-patients. In this study we aimed to evaluate acute DVT treatment pathways in our emergency department (ED) in practice and to identify barriers to outpatient management.

Read the article

October 13th is World Thrombosis Day, a global movement that aims to focus attention on thrombosis, an often overlooked and misunderstood condition. To mark the occasion we invited Tetsumei Urano, Associate Editor of Thrombosis Journal to tells us about the conditions that the day focuses on.

Read blog post here

State of the Art 2016: Research and Review from the 9th Congress of the Asian-Pacific Society on Thrombosis and Hemostasis

​​​​​​The 9th Congress of the Asian-Pacific Society on Thrombosis and Hemostasis was held from 6-9 October 2016 in Taipei, Taiwan.

As the official journal of the APSTH, Thrombosis Journal has published a supplement of state of the art review and research articles in conjunction with the congress.

Inflammation and its role in thrombosis

In recent years it has become increasingly clear that the immune system and coagulation pathways interact and influence one another. Inflammation-induced thrombosis is considered a feature of several autoimmune diseases and thus such findings have important consequences for the treatment and management of such diseases.

“It is with great pleasure that I join the Editorial team of Thrombosis Journal and to take on the role as co-Editor-in-Chief (EiC). This is indeed a great honor for me. For your information, I am a biochemist and have been active in the field of Thrombosis and Haemostasis with a particular interest in fibrinolysis for over 38 years. I am looking forward to making a positive contribution to Thrombosis Journal. I would very much like to thank and acknowledge the many years at the helm by my predecessor Prof Hugo Ten Cate. I will do my best to fill Hugo’s shoes. I would also like to acknowledge the long-lasting role of Yukio Ozaki as co-EiC who will be continuing in this role. I am looking forward to working with Prof Ozaki and the dedicated Associate Editors to develop and implement new ideas and approaches to improve the standing of the Journal.”

                                            Robert Medcalf, Editor-in-Chief, Thrombosis Journal